High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico

Sexually Transmitted Diseases

Volumn 32, Issue 10, 2005, Pages 613-618

  Hernández Girón, Carlos ^a   Smith, Jennifer S ^b   Lorincz, Attila ^c   Lazcano, Eduardo ^a   Hernández Ávila, Mauricio ^a   Salmerón, Jorge ^d  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b IL   (United States)

^c Digene Corporation   (United States)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNITY; MAJOR CLINICAL STUDY; MEXICO; PREGNANCY; PREVALENCE; RISK FACTOR; SCREENING TEST; SEXUAL BEHAVIOR; SOCIOECONOMICS; VERRUCA VULGARIS; VIRUS DETECTION; VIRUS REACTIVATION; WART VIRUS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; MEXICO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; RISK FACTORS; VAGINAL SMEARS;

EID: 26444453888     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000179888.47309.db     Document Type: Article

References (34)

1. Gerbase AC, Rowley JT, Mertens TE. Global epidemiology of sexually transmitted diseases. Lancet 1998; 351(suppl 3):2-4.
2. Galloway DA. Is vaccination against human papillomavirus a possibility? Lancet 1998; 351(suppl 3):22-24.
3. Dirección General de Epidemiología (DGE), Secretaría de Salud (SSA). Registro histopatológico de neoplasias en México; 1994.
4. Secretaría de Salud (SSA). Programa nacional de prevención y control del cancer cervicouterino 1995-2000; México 1995.
5. SSA. Dirección General De Información y Evaluación del Desempeño. Secretaría de Salud. Salud, México; 2001: Cancer Cervicouterino. SSA 2002.
6. Restrepo HE, González J, Roberts E, Litvak J. Epidemiología y control del cáncer del cuello uterino en América Latina y el Caribe. Bol Oficina Sanit Panam 1987; 102:578-593.
7. Schiffman MH. Epidemiology of cervical human papillomavirus infections. Curr Top Microbiol Immunol 1994; 186:56-81.
8. Muñoz N, Bosch FX, de Sanjosé S, et al. El virus del papiloma humano en la etiología del cancer cervicouterino. Bol Oficina Sanit Panam 1993; 115:301-309.
9. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55:244-265.
10. Ahdoot D, Van Nostrand KM, Nguyen NJ, et al. The effect of route of delivery on regression of abnormal cervical cytologic findings in the postpartum period. Am J Obstet Gynecol 1998; 178:1116-1120.
11. Autier P, Coibion M, Huet F, Grivegnee A. Transformation zone location and intraepithelial neoplasia of the cervix uteri. Br J Cancer 1996; 74:488-490.
12. Smith EM, Johnson SR, Cripe T, et al. Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev 1995; 19:196-205.
13. Flores Y, Shah K, Lazcano E, et al. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV study. Salud Pública Mex 2002; 44:335-344.
14. Lorincz A. Hybrid Capture method for detection of human papilloma-virus DNA in clinical specimens. Pap Report 1996; 7:1-5.
15. Instituto Nacional de Estadística Geográfia e Informática INEGI. XII Censo General de Población y Vivienda México; 2000.
16. Fife KH, Katz BP, Roush J, Handy VD, Brown DR, Hansell R. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am J Obstet Gynecol 1996; 174:1487-1493.
17. Schneider A, Hotz M, Gissmann L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer 1987; 40:198-201.
18. Gopalkrishna V, Murthy NS, Sharma JK, et al. Increased human papillomavirus infection with the increasing number of pregnancies in Indian women. J Infect Dis 1995; 171:254-255.
19. Watts DH, Koutsky LA, Holmes KK, et al. Low risk of perinatal transmission of human papillomavirus: Results from a prospective cohort study. Am J Obstet Gynecol 1998; 178:365-373.
20. Chang-Claude J, Schneider A, Smith E, Blettner M, Wahrendorf J, Turek L. Longitudinal study of the effects of pregnancy and other factor on detection of HPV. Gynecol Oncol 1996; 60:355-362.
21. Morrison EA, Gammon MD, Goldberg GL, Vermund SH, Burk RD. Pregnancy and cervical infection with human papillomaviruses. Int J Gynaecol Obstet 1996; 54:125-130.
22. Hagensee ME, Slavinsky J 3rd, Gaffga CM, Suros J, Kissinger P, Martin DH. Seroprevalence of human papillomavirus type 16 in pregnant women. Obstet Gynecol 1999; 94:653-658.
23. Terry G, Ho L, Londesborough P, Cuzick J, Mielzynska-Lohnas I, Lorincz A. Detection of high-risk HPV types by the Hybrid Capture 2 test. J Med Virol 2001; 65:155-162.
24. Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening. Results from women in a high-risk province of Costa Rica. JAMA 2000; 283:87-93.
25. Czegledy J, Gergely L, Endrodi I. Detection of human papillomavirus deoxyribonucleic acid by filter in situ hybridization during pregnancy. J Med Virol 1989; 28:250-254.
26. De Roda Husman AM, Walboomers JM, Hopman E, et al. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: The age-related pattern. J Med Virol 1995; 46:97-102.
27. Smith EM, Johnson SR, Jiang D, et al. The association between pregnancy and human papilloma virus prevalence. Cancer Detect Prev 1991; 15:397-402.
28. Soares VR, Nieminen P, Aho M, Vesterinen E, Vaheri A, Paavonen J. Human papillomavirus DNA in unselected pregnant and non-pregnant women. Int J STD AIDS 1990; 1:276-278.
29. Chan PK, Chang AR, Tam WH, Cheung JL, Cheng AF. Prevalence and genotype distribution of cervical human papillomavirus infection: Comparison between pregnant women and non-pregnant controls. J Med Virol 2002; 67:583-588.
30. Tenti P, Zappatore R, Migliora P, et al. Latent human papillomavirus infection in pregnant women at term: A case-control study. J Infect Dis 1997; 176:277-280.
31. Muñoz N, Franceschi S, Bosetti C, et al., for the International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer. Role of parity, human papillomavirus in cervical cancer: The IARC multicentric case-control study. Lancet 2002; 359:1093-1101.
32. Anh P, Hieu T, Herrero R, et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003; 104:213-220.
33. Shin H, Lee D, Herrero R, et al. Prevalence of human papillomavirus infections in women in Busan. South Korea. Int J Cancer 2003; 103:414-421.
34. Brinton L, Reeves W, Brenes M, et al. Parity as a risk factor for cervical cancer. Am J Epidemiol 1989; 130:486-495.